Hospital Regional Docente de Trujillo
Trujillo, La Libertad, 20230, Peru
NCT Number: NCT07053839
The goal of this clinical trial is to learn if a daily text reminder ("AdhasText") can help children with asthma use their inhalers regularly, control their symptoms, and improve their lung function. The main questions it aims to answer are:
Does the daily text reminder improve adherence to inhaled corticosteroids in children with asthma? Does the text reminder help children with asthma control their symptoms better? Does the text reminder improve lung function in children with asthma?
Researchers will compare children who receive the daily text reminder with usual care to children who receive usual care (without the reminder) to see if the text reminder improves adherence, symptom control, and lung function.
Participants will:
Receive a daily text reminder or usual care (no reminder) for 90 days Complete questionnaires about their asthma symptoms at 45 and 90 days Have spirometry tests to measure lung function at the start of the study and 90 days
Looking for future studies?
Notify Me5 year–14 year
All sexes
Interventional
Not applicable
Trujillo, La Libertad, 20230, Peru
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention, titled "AdhasText," involved sending a daily SMS reminder to caregivers, specifically mothers of children with asthma. The message, "If you want to stay healthy, you must use your inhaler," was sent at 7:00 p.m. over a 90 days period.
Time frame: 45 days (T1) and 90 days (T2) after the intervention
Inhaler adherence was measured using the Inhaler Adherence Scale for Children (IASC), which evaluates adherence across three domains: Cognitive, Psychosocial, and Control & Autonomy. The scale consists of 12 questions, with responses ranging from 0 (indicating poor adherence) to 4 (indicating full adherence) for each question. A higher total score indicates better adherence.
Time frame: Day 45 and day 90 after the intervention
Symptom control was assessed using the Asthma Control Test (ACT) for participants aged 12 years and older, and the Childhood Asthma Control Test (c-ACT) for children under 12 years old. The ACT consists of 5 questions regarding asthma symptoms, and the c-ACT includes 4 questions for the child and 3 for the caregiver. A higher score indicates better control over asthma symptoms.
Time frame: Baseline and day 90 after the intervention
Pulmonary function was assessed using spirometry at 90 days (T2). This measure evaluates the participants' lung function by assessing key parameters such as Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC). A bronchodilator response (BDR) was defined as an increase of more than 10% in FEV₁ or FVC following the administration of 400 µg of inhaled salbutamol; responses below this threshold indicated absence of BDR. Pulmonary function was categorized into four groups: (1) normal baseline spirometry without BDR (considered the only normal pattern), (2) normal baseline spirometry with BDR, (3) obstructive pattern without BDR, and (4) obstructive pattern with BDR. Additionally, lung function impairment severity was classified using z-score values: > -1.645 (normal), -1.65 to -2.5 (mild), -2.51 to -4 (moderate), and < -4.1 (severe).
ROXANA AZNARAN TORRES
Other
Effect of the Visual Reminder "AdhasText" on Adherence to Inhaled Corticosteroids, Symptom Control, and Pulmonary Function in Children With Asthma: A Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05793866
Asthma, Asthma in Children
Adana, Turkey (Türkiye)
View Trial DetailsNCT07029919
Adolescent Behavior, Asthma
Atlanta, Georgia, United States
View Trial DetailsNCT04918394
Asthma, Asthma in Children
Armentières, France
View Trial DetailsNCT04002362
Asthma, Asthma in Children
Atlanta, Georgia, United States
View Trial Details